Literature DB >> 32867573

4-HNE Immunohistochemistry and Image Analysis for Detection of Lipid Peroxidation in Human Liver Samples Using Vitamin E Treatment in NAFLD as a Proof of Concept.

Maren C Podszun1,2, Joon-Yong Chung3,2, Kris Ylaya3,2, David E Kleiner4,2, Stephen M Hewitt3,2, Yaron Rotman1,2.   

Abstract

Lipid peroxidation is a common feature of liver diseases, especially non-alcoholic fatty liver disease (NAFLD). There are limited validated tools to study intra-hepatic lipid peroxidation, especially for small specimen. We developed a semi-quantitative, fully automated immunohistochemistry assay for the detection of 4-hydroxynoneal (4-HNE) protein adducts, a marker of lipid peroxidation, for adaptation to clinical diagnostics and research. We used Hep G2 cells treated with 4-HNE to validate specificity, sensitivity, and dynamic range of the antibody. Staining and semi-quantitative automated readout were confirmed in human needle-biopsy liver samples from subjects with NAFLD and normal liver histology. The ability to detect changes in lipid peroxidation was tested in paired liver biopsies from NAFLD subjects, obtained before and after 4 weeks of treatment with the antioxidant vitamin E (ClinicalTrials.gov NCT01792115, n=21). The cellular calibrator was linear and NAFLD patients had significantly higher levels of 4-HNE adducts compared to controls (p=0.02). Vitamin E treatment significantly decreased 4-HNE (p=0.0002). Our findings demonstrate that 4-HNE quantification by immunohistochemistry and automated image analysis is feasible and able to detect changes in hepatic lipid peroxidation in clinical trials. This method can be applied to archival and fresh samples and should be considered for use in assessing NAFLD histology.

Entities:  

Keywords:  4-HNE adducts; 4-hydroxynonenal; NAFLD; immunoassay; immunohistochemistry; lipid peroxidation

Mesh:

Substances:

Year:  2020        PMID: 32867573      PMCID: PMC7649917          DOI: 10.1369/0022155420946402

Source DB:  PubMed          Journal:  J Histochem Cytochem        ISSN: 0022-1554            Impact factor:   2.479


  33 in total

1.  Oxidative stress biomarkers in the serum and plasma of patients with non-alcoholic fatty liver disease (NAFLD). Can plasma AGE be a marker of NAFLD? Oxidative stress biomarkers in NAFLD patients.

Authors:  Magdalena Świderska; Mateusz Maciejczyk; Anna Zalewska; Joanna Pogorzelska; Robert Flisiak; Adrian Chabowski
Journal:  Free Radic Res       Date:  2019-07-08

2.  Intra- and interobserver reproducibility of interpretation of immunohistochemical stains of prostate cancer.

Authors:  Sara Jonmarker Jaraj; Philippe Camparo; Helen Boyle; François Germain; Bo Nilsson; Fredrik Petersson; Lars Egevad
Journal:  Virchows Arch       Date:  2009-09-18       Impact factor: 4.064

3.  Fiji: an open-source platform for biological-image analysis.

Authors:  Johannes Schindelin; Ignacio Arganda-Carreras; Erwin Frise; Verena Kaynig; Mark Longair; Tobias Pietzsch; Stephan Preibisch; Curtis Rueden; Stephan Saalfeld; Benjamin Schmid; Jean-Yves Tinevez; Daniel James White; Volker Hartenstein; Kevin Eliceiri; Pavel Tomancak; Albert Cardona
Journal:  Nat Methods       Date:  2012-06-28       Impact factor: 28.547

4.  Expression of toll-like receptors 1-5 but not TLR 6-10 is elevated in livers of patients with non-alcoholic fatty liver disease.

Authors:  Giridhar Kanuri; Ruth Ladurner; Julia Skibovskaya; Astrid Spruss; Alfred Königsrainer; Stephan C Bischoff; Ina Bergheim
Journal:  Liver Int       Date:  2014-01-12       Impact factor: 5.828

5.  Pioglitazone, vitamin E, or placebo for nonalcoholic steatohepatitis.

Authors:  Arun J Sanyal; Naga Chalasani; Kris V Kowdley; Arthur McCullough; Anna Mae Diehl; Nathan M Bass; Brent A Neuschwander-Tetri; Joel E Lavine; James Tonascia; Aynur Unalp; Mark Van Natta; Jeanne Clark; Elizabeth M Brunt; David E Kleiner; Jay H Hoofnagle; Patricia R Robuck
Journal:  N Engl J Med       Date:  2010-04-28       Impact factor: 91.245

6.  Hepatic lipid peroxidation and cytochrome P-450 2E1 in pediatric nonalcoholic fatty liver disease and its subtypes.

Authors:  Lauren N Bell; Jean P Molleston; Michael J Morton; Ann Klipsch; Romil Saxena; Raj Vuppalanchi; Naga Chalasani
Journal:  J Clin Gastroenterol       Date:  2011-10       Impact factor: 3.062

7.  Design and validation of a histological scoring system for nonalcoholic fatty liver disease.

Authors:  David E Kleiner; Elizabeth M Brunt; Mark Van Natta; Cynthia Behling; Melissa J Contos; Oscar W Cummings; Linda D Ferrell; Yao-Chang Liu; Michael S Torbenson; Aynur Unalp-Arida; Matthew Yeh; Arthur J McCullough; Arun J Sanyal
Journal:  Hepatology       Date:  2005-06       Impact factor: 17.425

8.  Rapid sample preparation and simultaneous quantitation of prostaglandins and lipoxygenase derived fatty acid metabolites by liquid chromatography-mass spectrometry from small sample volumes.

Authors:  Ines Unterwurzacher; Therese Koal; Guenther K Bonn; Klaus M Weinberger; Steven L Ramsay
Journal:  Clin Chem Lab Med       Date:  2008       Impact factor: 3.694

9.  Measurement of HNE-protein adducts in human plasma and serum by ELISA-Comparison of two primary antibodies.

Authors:  Daniela Weber; Lidija Milkovic; Stuart J Bennett; Helen R Griffiths; Neven Zarkovic; Tilman Grune
Journal:  Redox Biol       Date:  2013-02-08       Impact factor: 11.799

10.  Expression of fibroblast growth factor receptor family members is associated with prognosis in early stage cervical cancer patients.

Authors:  Chel Hun Choi; Joon-Yong Chung; Jae-Hoon Kim; Byoung-Gie Kim; Stephen M Hewitt
Journal:  J Transl Med       Date:  2016-05-06       Impact factor: 5.531

View more
  5 in total

1.  Protecting mitochondria via inhibiting VDAC1 oligomerization alleviates ferroptosis in acetaminophen-induced acute liver injury.

Authors:  Baolin Niu; Xiaohong Lei; Qingling Xu; Yi Ju; Dongke Xu; Liya Mao; Jing Li; Yufan Zheng; Ning Sun; Xin Zhang; Yimin Mao; Xiaobo Li
Journal:  Cell Biol Toxicol       Date:  2021-08-17       Impact factor: 6.691

Review 2.  Immunological mechanisms and therapeutic targets of fatty liver diseases.

Authors:  Hua Wang; Wajahat Mehal; Laura E Nagy; Yaron Rotman
Journal:  Cell Mol Immunol       Date:  2020-12-02       Impact factor: 11.530

Review 3.  Genetic Factors Associated with Response to Vitamin E Treatment in NAFLD.

Authors:  Mehtap Civelek; Maren C Podszun
Journal:  Antioxidants (Basel)       Date:  2022-06-28

4.  Wheat germ oil vitamin E cytoprotective effect and its nutrigenomics signature in human hepatocyte lipotoxicity.

Authors:  Desirée Bartolini; Rita Marinelli; Anna Maria Stabile; Tiziana Frammartino; Angela Guerrini; Stefano Garetto; Jacopo Lucci; Anna Migni; Linda Zatini; Giada Marcantonini; Mario Rende; Francesco Galli
Journal:  Heliyon       Date:  2022-09-23

5.  Dynamics of Serum Retinol and Alpha-Tocopherol Levels According to Non-Alcoholic Fatty Liver Disease Status.

Authors:  Dongsub Jeon; Minkook Son; Juhyun Shim
Journal:  Nutrients       Date:  2021-05-19       Impact factor: 5.717

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.